Search

Search Constraints

You searched for: Author/Creator Masi, Gianluca

Search Results

1. A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice. (9th March 2018)

2. Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib. (22nd July 2021)

3. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023)

4. Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature. (February 2022)

5. Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable. Issue 2 (9th May 2019)

6. Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database. Issue 1 (January 2015)

7. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC): an option for patients (pts) with uncommon histologies (UH)?. Issue 2 (February 2022)

9. Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. (March 2017)